DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

DJ Weisenberger, G Liang, HJ Lenz - Oncogene, 2018 - nature.com
Colorectal cancer (CRC) is a worldwide health concern with respect to both incidence and
mortality, and as a result, CRC tumorigenesis, progression and metastasis have been …
被引用次数：82 相关文章

DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.

DJ Weisenberger, G Liang, HJ Lenz - Oncogene, 2017 - europepmc.org
Colorectal cancer (CRC) is a worldwide health concern with respect to both incidence and
mortality, and as a result, CRC tumorigenesis, progression and metastasis have been …
[HTML] nih.gov

[HTML][HTML] DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

DJ Weisenberger, G Liang, HJ Lenz - Oncogene, 2018 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is a worldwide health concern with respect to both incidence and
mortality, and as a result, CRC tumorigenesis, progression and metastasis have been …

[引用][C] DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

DJ Weisenberger, G Liang, HJ Lenz - Oncogene, 2017 - cir.nii.ac.jp
DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and
provide novel targets for epigenetic therapies | CiNii Research CiNii 国立情報学研究所 学術 …

DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

DJ Weisenberger, G Liang, HJ Lenz - Oncogene, 2018 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is a worldwide health concern with respect to both incidence and
mortality, and as a result, CRC tumorigenesis, progression and metastasis have been …

DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

DJ Weisenberger, G Liang, HJ Lenz - Oncogene, 2018 - go.gale.com
Colorectal cancer (CRC) is a significant global health burden, with an incidence of 1.4
million cases and~ 700 000 deaths worldwide in 2012.[1] CRC is the third leading cause of …